The DoH recommends that statin therapy should be given to all patients at risk of a stroke and that warfarin should be given to patients with AF.
The proposals form part of a number of action plans set out in the DoH’s 10-year National Stroke Strategy, which was announced last week.
The £105 million strategy aims to accelerate the emergency response to stroke, by setting out a framework for care for those affected by stroke and raising awareness about symptoms and risk factors.
The strategy calls for ‘statin therapy for all people with more than a 20 per cent risk of cardiovascular disease within 10 years’.
But RCGP vice chairman Dr Graham Archard said that ‘blanket coverage’ of statin use for all patients would not be beneficial.
‘I can understand the logic behind the proposal but there is no hard evidence to suggest that it will work.
‘There is no evidence to show that people over the age of 80 will benefit from statin therapy. It is just another pill to swallow.’
They should give statins to patients based on improvements in life expectancy, he said.
The strategy also calls for warfarin to be given to AF patients.
However, Surrey GP Dr John Pittard, a member of the Primary Care Cardiovascular Society, said: ‘Warfarin does benefit patients with AF but many of them are reluctant to go on warfarin because of the complications and drug interactions associated with its use.
‘It is a very high maintenance drug that requires a lot of blood test monitoring.’
It will also be difficult for patients to maintain the correct dosage levels especially if they have just suffered a stroke, said Dr Pittard.
The strategy also states that access to MRI scans will be provided for all high-risk individuals with TIAs within 24 hours of experiencing symptoms and within seven days for low-risk individuals.
It is estimated that this could lead to an 80 per cent reduction in the number of people who go on to have a full stroke.
Comment below and tell us what you think